Where is Onkos located?

Onkos is headquartered in Brazil.

Where does Onkos rank among its competitors?

Onkos ranks 262nd amongst 275 active competitors, of which 11 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Orange Health, which secured $30M in May, 2026.

Who are the top competitors of Onkos?

Onkos' top competitors include Dr Lal PathLabs, MedGenome and Orange Health. Among them, Orange Health secured the most recent funding round in May, 2026.

Onkos - 2026 Company Profile & Competitors

Onkos is an unfunded company based in Brazil. It operates as a Developer of molecular diagnostic tests for oncology and thyroid conditions. Onkos has not raised any funding yet. The company has 275 active competitors, including 11 funded and 32 that have exited. Its top competitors include companies like Dr Lal PathLabs, MedGenome and Orange Health.

Company Details

Developer of molecular diagnostic tests for oncology and thyroid conditions. The company provides diagnostic and prognostic tools, including molecular classifiers for indeterminate thyroid nodules. These tests assist in medical decision-making, such as determining the necessity of surgery. The company focuses on developing tests based on gene expression profiling.

Key Metrics

Location

Brazil

Stage

Unfunded

Ranked

262^nd among 275 active competitors

Similar Companies

MedGenome & 114 more

View Onkos' full profile

Onkos has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Onkos include Dr Lal PathLabs, MedGenome and Orange Health. Here is the list of Top 10 competitors of Onkos, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Dr Lal PathLabs 1949, Gurugram (India), Public	Chain of pathology and radiology labs	$13.9M	WestBridge Capital, TA Associates & 4 others	79/100
2nd	MedGenome 2013, Bengaluru (India), Series E	Provider of DNA sequencing, bioinformatics, and multiomics services	$264M	Novo Holdings, Peak XV Partners & 30 others	70/100
3rd	Orange Health 2020, Bengaluru (India), Series C	Chains providing at-home diagnostic testing and health checkup services	$77.1M	Bertelsmann India Investments, Iron Pillar ... & 16 others	69/100
4th	Metropolis India 1981, Mumbai (India), Public	Chain of diagnostic centers	$232M	Warburg Pincus, The Carlyle Group & 13 others	68/100
5th	LifeLabs 1998, Toronto (Canada), Acquired	Chain of pathology labs	-	OMERS Infrastructure	57/100
6th	Aidikang Medical Laboratory Center 2004, Hangzhou (China), Public	Chain of pathology labs	$88M	Khazanah Nasional Berhad, The Carlyle Group ... & 5 others	53/100
7th	CORE 2012, Gurugram (India), Acquired	Laboratory offering biomarker analysis	$17.3M	Artiman, Innoven Capital & 2 others	53/100
8th	Lilac Insights 2011, Mumbai (India), Series A	Provider of genetic diagnostic advisory services for infant	$11M	Tara Fund, Ranay Shah Family Trust & 53 others	52/100
9th	Sterling Accuris Diagnostics 2015, Ahmedabad (India), Series C	Chain of pathology labs	$41.7M	Udhay Vi Realty, Morgan Stanley & 11 others	51/100
10th	Dr Dangs Lab 1983, Delhi (India), Unfunded	Provider of diagnostic testing services in various medical specialties	-	-	50/100
262nd	Onkos Brazil, Unfunded	Developer of molecular diagnostic tests for oncology and thyroid conditions	-	-	16/100